[The therapeutic modification of the primary vascular form of chronic cor pulmonale and of continuing pulmonary hypertension after commissurotomy for mitral stenosis. A comparison with control of the pulmonary artery pressure].
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000328:Adult; D001794:Blood Pressure; D002302:Cardiac Output; D006348:Cardiac Surgical Procedures / Q000009:adverse effects*; D005260:Female; D006339:Heart Rate; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D008875:Middle Aged; D008946:Mitral Valve Stenosis / Q000601:surgery*; D005996:Nitroglycerin / Q000627:therapeutic use; D010646:Phentolamine / Q000627:therapeutic use; D011651:Pulmonary Artery / Q000503:physiopathology; D011660:Pulmonary Heart Disease / Q000188:drug therapy*; D012110:Reserpine / Q000627:therapeutic use; D014655:Vascular Resistance; D014665:Vasodilator Agents / Q000627:therapeutic use; D014700:Verapamil / Q000627:therapeutic use
D000317:Adrenergic alpha-Antagonists; D000318:Adrenergic beta-Agonists; D014665:Vasodilator Agents; D012110:Reserpine; D014700:Verapamil; D005996:Nitroglycerin; D010646:Phentolamine
Die therapeutische Beeinflussung der primär vaskulären Form des chronischen Cor pulmonale und der weiterbestehenden pulmonalen Hypertonie nach Kommissurotomie der Mitralstenose. Ein Vergleich unter Kontrolle des Pulmonalarteriendruckes.